HCPLive Network
  • IDWeek 2014
  • Chronic Pain Peer Exchange Video Series
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Monday, October 20, 2014
By Amy Jacob
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
Monday, October 20, 2014
By Andrew Smith
New research provides some of the first concrete support for a treatment guideline that has long been recommended on grounds of common sense alone: Patients who suffer severe allergic reactions such as anaphylaxis should follow up on their emergency room care by seeing an allergist or immunologist.
Monday, October 20, 2014
Children may be at lower risk of Ebola virus disease, but physicians should be aware of the signs and symptoms, according to a viewpoint piece published online Oct. 17 in JAMA Pediatrics.
Monday, October 20, 2014
By Rachel Lutz
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
Monday, October 20, 2014
By Rachel Lutz
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
Monday, October 20, 2014
A stuffed, plush Ebola virus toy sold out in days at Giant Microbes, an online store. Halloween stores report they have run out of HazMat suits bought as Ebola-themed costumes. Sheltering children from frightening news is hard in this global, multi-media world. Naturally, a lot of kids have questions about Ebola, the lethal pathogen that is devastating parts of West Africa, and has spread to the US and other countries. What should we tell them?
Monday, October 20, 2014
By Gale Scott
Could portable perfusion devices be a game-changer for organ transplants? The machines keep organs “alive” for days at warm temperatures. That prolongs cell life, slowing the race against the damage that can set in within hours when donor organs are kept on ice in coolers. Manufacturer TransMedics, based in Andover, MA, makes devices for the lung, heart, and liver Researchers and clinicians express growing excitement—along with some skepticism—at the prospect that these medical devices could dramatically increase the viability of donor organs
Monday, October 20, 2014
The incidence of young-onset colorectal cancer is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
Monday, October 20, 2014
A formal yoga program may be beneficial for pediatric patients newly diagnosed with inflammatory bowel disease, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
Monday, October 20, 2014
By Gale Scott
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
Email Signup
Breaking News
Ron Klain, who was chief of staff to Vice President Joe Biden and former Vice President Al Gore, will be Obama’s point-man for dealing with the Ebola outbreak. The New York Times reported that Klain’s duties will involve handling the nation’s response to Ebola both domestically and in Africa.
News that a nurse at Texas Presbyterian Hospital in Dallas diagnosed with Ebola had earlier made a round trip to Cleveland, OH raised questions about whether voluntary isolation agreements enforced by local health authorities are adequate to protect the public from the virus. President Barack Obama canceled travel plans to hold an Ebola meeting with his cabinet and a new report found the virus could spread through respiratory secretions--contrary to what the feds have been saying.
Pirfenidone has been approved in Europe for the treatment of idiopathic pulmonary fibrosis (IPF) since 2011, whereas this is the first approval for nintedanib for the treatment of IPF.
Physician's Money Digest
Really smart investors tend to have their own unique style. But dumb ones are all the same. They tend to be ignorant of stock market history. And they act - or, more to the point, react - not rationally but emotionally.
This week's PMD Critical List looks at the return of house calls, the advent of physician "mechanics," and the tough civil liberties questions posted by the Ebola virus.
Product News
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
The US Food and Drug Administration (FDA) has approved the use of an experimental drug to treat patients who have Ebola Virus Disease.
Trulicity (dulaglutide) is a once-weekly subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
The FDA has approved Baxter’s Rixubis [Coagulation Factor IX (Recombinant)], an intravenous prophylactic treatment intended to control and prevent bleeding episodes and assist with perioperative management for children 12 years and younger with hemophilia B.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?